Your Location：
Home >
Browse articles >
Immune cells: potential carriers or agents for drug delivery to the central nervous system
REVIEW | Updated：2025-02-24

    • Immune cells: potential carriers or agents for drug delivery to the central nervous system

    • “In the field of drug delivery systems, researchers have made significant progress. They have outlined the three major brain barriers in the CNS and reviewed biomimetic strategies utilizing immune cell-based nanoparticles for drug delivery to the CNS, laying a foundation for the construction of drug delivery systems.”
    • Military Medical Research   Vol. 12, Issue 1, Pages: 121-153(2025)

    • DOI：10.1186/s40779-024-00521-y    

      CLC：

    • Published：2025-01

    Scan QR Code

  • Cite this article as: Zhang SS, Li RQ, Chen Z, Wang XY, Dumont AS, Fan X. Immune cells: potential carriers or agents for drug delivery to the central nervous system. Mil Med Res. 2024;11(1):19. DOI： 10.1186/s40779-024-00521-y.

  •  
  •  

0

Views

0

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Targeting the central and peripheral nervous system to regulate bone homeostasis:mechanisms and potential therapies
Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood–brain barrier injury through the Wnt/β-catenin signalling pathway
Neuroregeneration and plasticity: a review of the physiological mechanisms for achieving functional recovery postinjury
Numerical Simulation of 3D Air-Charging Model of the Heavy Haul Train Air Brake Pipes System
Research on Wheel/Rail Action of Heavy Haul Train

Related Author

Ling Qin
Fan Yang
Jian-Kun Xu
Ye Li
Zi-Yi Chen
Yue-Jun Lin
Zhe-Yu Jin
Tong-Zhou Liang

Related Institution

Musculoskeletal Research Laboratory of Department of Orthopaedics& Traumatology and Innovative Orthopaedic Biomaterial and Drug Translational Research Laboratory, Li Ka Shing Institute of Health, the Chinese University of Hong Kong
Innovative Orthopedic Biomaterial and Drug Translational Research Laboratory, Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, the Chinese University of Hong Kong
The Brain Cognition and Brain Disease Institute (BCBDI), Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions
Areas of Excellence Centre for Musculoskeletal Degeneration and Regeneration
Department of Neurology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, No. 134, Dongjie, Gulou District
0